Drugs in R&D

Proteasome Inhibitors in the Clinical Setting: Benefits and Strategies to Overcome Multiple Myeloma Resistance to Proteasome Inhibitors
pp. 1-12(12)
Authors: Cheriyath, Venugopalan; Jacobs, Barbara S.; Hussein, Mohamad A.

Role of Adenosine Receptors in the Treatment of Asthma and Chronic Obstructive Pulmonary Disease: Recent Developments
pp. 13-23(11)
Authors: Maarten van den Berge,; Hylkema, Machteld N.; Versluis, Mieke; Postma, Dirkje S.

Respiratory System Involvement in Antineutrophil Cytoplasmic-Associated Systemic Vasculitides: Clinical, Pathological, Radiological and Therapeutic Considerations
pp. 25-42(18)
Authors: Pesci, Alberto; Manganelli, Paolo

Nasogastric Administration of Garenoxacin as Crushed Tablets With and Without Concomitant Enteral Feeding in Healthy Subjects
pp. 43-50(8)
Authors: Krishna, Gopal; Noveck, Robert; Vargas, Ramon; Grasela, Dennis; Wang, Zaiqi

Tramadol has a Better Potency Ratio Relative to Morphine in Neuropathic than in Nociceptive Pain Models
pp. 51-57(7)
Authors: Christoph, Thomas; Kögel, Babette; Strassburger, Wolfgang; Schug, Stephan A.

Eculizumab: 5G1.1, h5G1.1, Long-Acting Anti-C5 Monoclonal Antibody 5G1-1, Long-Acting Anti-C5 Monoclonal Antibody 5G1.1
pp. 61-68(8)
Author: Adis International Limited,